Literature DB >> 6762614

Thrombotic thrombocytopenic purpura: a review.

R M Bukowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6762614

Source DB:  PubMed          Journal:  Prog Hemost Thromb        ISSN： 0362-6350


× No keyword cloud information.
  19 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.

Authors:  Satoru Kosugi; Masanori Matsumoto; Yasushi Ohtani; Hironori Take; Hiromichi Ishizashi; Yoshihiro Fujimura; Jun Kuyama
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

Review 3.  ADAMTS13 and microvascular thrombosis.

Authors:  Han-Mou Tsai
Journal:  Expert Rev Cardiovasc Ther       Date:  2006-11

4.  National questionnaire survey of TMA.

Authors:  Naomi Ito; Hideo Wada; Masanori Matsumoto; Yoshihiro Fujimura; Mitsuru Murata; Takashi Izuno; Minoru Sugita; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2009-09-18       Impact factor: 2.490

5.  Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?

Authors:  Wenhua Zhou; Lingli Dong; David Ginsburg; Eric E Bouhassira; Han-Mou Tsai
Journal:  J Biol Chem       Date:  2005-10-03       Impact factor: 5.157

6.  Measurement of ADAMTS13.

Authors:  Han-Mou Tsai
Journal:  Int Rev Thromb       Date:  2006

Review 7.  The role of splenectomy in the treatment of relapsing thrombotic thrombocytopenic purpura.

Authors:  G A Veltman; A Brand; O C Leeksma; G J ten Bosch; J H van Krieken; E Briët
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

Review 8.  Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

Review 9.  The kidney in thrombotic thrombocytopenic purpura.

Authors:  H-M Tsai
Journal:  Minerva Med       Date:  2007-12       Impact factor: 4.806

Review 10.  Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.

Authors:  Roslyn Yomtovian; Waldemar Niklinski; Bernard Silver; Ravindra Sarode; Han-Mou Tsai
Journal:  Br J Haematol       Date:  2004-03       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.